Herbal-Review.com

American Cancer Society - Researchers at Massachusetts General Hospital (MGH) are testing a
non-surgical technique that may help doctors monitor how well non-small
cell lung cancer patients are responding to treatment. Using a device
known as a CTC-chip to analyze circulating tumor cells from patients’
blood samples, the scientists were able to identify whether patients
had genetic mutations that would make them less likely to respond to
certain therapies.